The global ophthalmic photocoagulator market size is accounted to grow at a significant CAGR of around 4.5% during the forecast period 2021 to 2027. The increasing incidence of eye disorder, diabetes, and age-related ophthalmic complications are some major factors to drive the market growth. The growing geriatric population around the world is further anticipated to boost the market. Furthermore, the increasing incidence of diabetes and diabetes-related blindness is anticipated to fuel the market over the forecast period. As per the information shared by the International Diabetes Federation, about 8.8% of the world’s population was diagnosed with diabetes in 2019, and this is expected to reach approximately 642 million by 2040.
Market Drivers:
Increasing Prevalence of Ophthalmic Disorders: The rising prevalence of ophthalmic disorders, such as diabetic retinopathy, age-related macular degeneration, and glaucoma, is a significant driving factor for the ophthalmic photocoagulator market. Ophthalmic photocoagulation is a widely used treatment method for these conditions, where laser energy is used to seal leaking blood vessels, reduce abnormal blood vessel growth, and control intraocular pressure. The growing number of patients with ophthalmic disorders drives the demand for ophthalmic photocoagulators.
Advancements in Laser Technology: Technological advancements in laser technology have significantly improved the performance and efficiency of ophthalmic photocoagulators. The development of advanced lasers, such as solid-state lasers and diode lasers, has led to more precise and targeted treatments with better patient outcomes. These advancements, including enhanced laser control, increased energy delivery options, and improved safety features, drive the adoption of ophthalmic photocoagulators by ophthalmologists.
Growing Aging Population: The global aging population is a key driver for the ophthalmic photocoagulator market. Age-related ophthalmic disorders, such as age-related macular degeneration and cataracts, are more prevalent in older adults. Ophthalmic photocoagulation is an effective treatment method for managing these conditions and preserving vision. As the aging population increases, the demand for ophthalmic photocoagulators is expected to grow.
Increasing Awareness and Diagnosis of Ophthalmic Disorders: There is a growing awareness of ophthalmic disorders and the importance of early diagnosis and treatment. Advances in screening technologies and increased awareness campaigns have resulted in more people seeking ophthalmic examinations and receiving timely treatment. Ophthalmic photocoagulation, as a widely recognized and effective treatment method, benefits from the increased awareness and diagnosis of ophthalmic disorders.
Rising Healthcare Expenditure: The overall increase in healthcare expenditure, particularly in the field of ophthalmology, drives the demand for ophthalmic photocoagulators. Governments and healthcare organizations are allocating more resources to address ophthalmic disorders and improve access to ophthalmic treatments. The investment in healthcare infrastructure and the availability of reimbursement policies for ophthalmic procedures contribute to the growth of the ophthalmic photocoagulator market.
Technological Integration and Workflow Optimization: Ophthalmic photocoagulators are increasingly being integrated with other diagnostic and imaging technologies, such as optical coherence tomography (OCT) and fundus cameras. This integration allows ophthalmologists to have a comprehensive view of the eye and facilitates efficient treatment planning and follow-up care. The integration of technologies and workflow optimization enhances the usability and effectiveness of ophthalmic photocoagulators.
Surge in Minimally Invasive Treatment Approaches: Minimally invasive treatment approaches are gaining popularity in ophthalmology, including ophthalmic photocoagulation. These approaches offer advantages such as faster recovery, reduced risk of complications, and improved patient comfort. Ophthalmic photocoagulators enable minimally invasive treatments, making them a preferred choice for both patients and ophthalmologists.
Market Snapshot:
| Benchmark Year | 2022 | ||
| Market Size | lock | ||
| Market Growth (CAGR) | ~ 4.5% (2023 to 2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Alcon Inc., Quantel Medical, Lumenis, ALMA, and IRIDEX Corporation |
Market Insights:
The global ophthalmic photocoagulator market is bifurcated into the application, clinical condition, end-use, and geography. On the basis of application, the market is further segmented into retinal laser photocoagulation, laser trabeculoplasty, iridotomy, and others. The retinal laser photocoagulation segment is estimated to hold a significant market share due to the increasing prevalence of age-related macular degeneration. Furthermore, the changing lifestyle and unhealthy dietary habits are anticipated to drive the segment growth. On the other hand, the increasing demand for minimally invasive procedures is expected to increase the demand for laser trabeculoplasty.
On the basis of clinical condition, the market is classified into Diabetic Retinopathy, Glaucoma, and Others. The diabetic retinopathy segment dominated the global ophthalmic photocoagulator market in 2020 and estimated to hold the largest revenue share of around one-third percent of the market. The growing prevalence rate of diabetes across the globe is a major factor to drive the segment growth. As per the information shared by World Health Organization (WHO), diabetes is the leading cause of new cases of blindness in adults and it is estimated that 1.5 million deaths occur due to diabetes in 2019.
To know more about the study, request sample papers
The ophthalmic photocoagulator comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.
The ophthalmic photocoagulator market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.
Market Segmentation:
By Application:
- Retinal Laser Photocoagulation
- Laser Trabeculoplasty
- Iridotomy
- Iridoplasty
- Others
By Clinical Condition:
- Diabetic Retinopathy
- Glaucoma
- Age-related Macular Degeneration
- Macular Edema
- Others
By End-Use:
- Hospitals
- Ambulatory Surgery Centers
- Ophthalmology Clinics
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage:
Geographically, North America dominated the global ophthalmic photocoagulator market in 2020 and estimated to hold the largest market share of over one-third percent of the market. The increasing incidence of chronic eye-related diseases and the rising prevalence of diabetes are some major factors to drive the market growth in the region. Furthermore, the prevalence of age-related macular degeneration and the rapid growth in the aging population is anticipated to boost the market in North America. On the other hand, the Asia Pacific is accounted to grow at the fastest growth rate over the forecast period.
Competition Assessment:
Some of the leading market players operating in the global ophthalmic photocoagulator market are Alcon Inc., Quantel Medical, Lumenis, ALMA, and IRIDEX Corporation. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Alcon Inc.
- Quantel Medical
- Lumenis
- ALMA
- IRIDEX Corporation
- NIDEK CO., LTD.
- Johnson & Johnson Vision Care, Inc.
- TOPCON CORPORATION
- Bausch & Lomb Incorporated
- Meridian Medical Group
Key Questions Answered by Ophthalmic Photocoagulator Market Report
- Global ophthalmic photocoagulator market forecasts from 2021-2027
- Regional ophthalmic photocoagulator market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
- Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
- Ophthalmic photocoagulator submarket forecasts from 2021-2027 covering the market by application, by clinical condition, by end-use, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the ophthalmic photocoagulator market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level ophthalmic photocoagulator markets from 2021-2027
- Competitive Landscape and market positioning of top 10 players operating in the ophthalmic photocoagulator market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Ophthalmic Photocoagulator Market Portraiture
2.2. Global Ophthalmic Photocoagulator Market, by Application, 2020 (USD Mn)
2.3. Global Ophthalmic Photocoagulator Market, by Clinical Condition, 2020 (USD Mn)
2.4. Global Ophthalmic Photocoagulator Market, by End-Use, 2020 (USD Mn)
2.5. Global Ophthalmic Photocoagulator Market, by Geography, 2020 (USD Mn)
3. Global Ophthalmic Photocoagulator Market Analysis
3.1. Ophthalmic Photocoagulator Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis
4. Global Ophthalmic Photocoagulator Market By Application, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Retinal Laser Photocoagulation
4.3. Laser Trabeculoplasty
4.4. Iridotomy
4.5. Iridoplasty
4.6. Others
5. Global Ophthalmic Photocoagulator Market By Clinical Condition, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Diabetic Retinopathy
5.3. Glaucoma
5.4. Age-related Macular Degeneration
5.5. Macular Edema
5.6. Others
6. Global Ophthalmic Photocoagulator Market By End-Use, 2018 – 2027 (USD Mn)
6.1. Overview
6.2. Hospitals
6.3. Ambulatory Surgery Centers
6.4. Ophthalmology Clinics
7. North America Ophthalmic Photocoagulator Market Analysis and Forecast, 2018 – 2027 (USD Mn)
7.1.1. Overview
7.1.2. North America Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
7.1.3. North America Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
7.1.4. North America Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
7.1.5. North America Ophthalmic Photocoagulator Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
7.1.5.1.2. U.S. Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
7.1.5.1.3. U.S. Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
7.1.5.2.2. Canada Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
7.1.5.2.3. Canada Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8. Europe Ophthalmic Photocoagulator Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. Europe Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.3. Europe Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.4. Europe Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8.1.5. Europe Ophthalmic Photocoagulator Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.5.1.2. Germany Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.5.1.3. Germany Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.5.2.2. U.K. Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.5.2.3. U.K. Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.5.3.2. France Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.5.3.3. France Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.5.4.2. Italy Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.5.4.3. Italy Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
9. Asia Pacific Ophthalmic Photocoagulator Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Asia Pacific Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
9.1.3. Asia Pacific Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
9.1.4. Asia Pacific Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
9.1.5. Asia Pacific Ophthalmic Photocoagulator Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
9.1.5.1.2. China Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
9.1.5.1.3. China Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
9.1.5.2.2. Japan Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
9.1.5.2.3. Japan Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
10. Latin America (LATAM) Ophthalmic Photocoagulator Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. Latin America Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
10.1.3. Latin America Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
10.1.4. Latin America Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
10.1.5. Latin America Ophthalmic Photocoagulator Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
10.1.5.1.2. Brazil Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
10.1.5.1.3. Brazil Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
10.1.5.2.2. Mexico Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
10.1.5.2.3. Mexico Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
11. Middle East and Africa Ophthalmic Photocoagulator Market Analysis and Forecast, 2018 – 2027 (USD Mn)
11.1.1. Overview
11.1.2. MEA Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
11.1.3. MEA Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
11.1.4. MEA Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
11.1.5. Middle East and Africa Ophthalmic Photocoagulator Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
11.1.5.1.2. GCC Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
11.1.5.1.3. GCC Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
11.1.5.2.2. South Africa Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
11.1.5.2.3. South Africa Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Ophthalmic Photocoagulator Market by Application (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Ophthalmic Photocoagulator Market by Clinical Condition (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Ophthalmic Photocoagulator Market by End-Use (2018-2027 USD Mn)
12. Company Profiles
12.1. Alcon Inc.
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Quantel Medical
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Lumenis
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. ALMA
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. IRIDEX Corporation
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. NIDEK CO., LTD.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Johnson & Johnson Vision Care, Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. TOPCON CORPORATION
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Bausch & Lomb Incorporated
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Meridian Medical Group
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
Still have questions? Get 15 minutes free consultation with our market expert before making a purchase.
We understand that every business has unique requirements. This report can be customized based on:
- Regional and country-level insights
- Specific application/industry breakdown
- Competitor benchmarking
- Market entry strategies
- Markets in over 100+ countries analyzed granularly
- 35% of our total client are returning clients
- 1000+ customers globally
- 100+ paid data sources mined to bring cutting-edge insights
- 24x5 availability - we are always there when you need us
- "Free of Cost Report Customization" is available
- Request a regional report at Best Price
- Data Historian Market Report
- Student Information System Market Report
- Smart Gas Meters Market Report
- Smart Highway Market Report
- Phytosterols Market Report
- Phytosterol Market Report
- Cheese Powder Market Report
- Polypropylene Packaging Films Market Report
- Butyric Acid Derivatives Market Report
- Market Report
- Unmanned Traffic Management Market Report
- Baking Enzymes Market Report
Our Clients
